What is Recursion Pharmaceuticals, Inc.'s AOCI?

Recursion Pharmaceuticals, Inc. (RXRX) reported AOCI of $26.66M in Q1 2026.

How has Recursion Pharmaceuticals, Inc.'s AOCI changed year-over-year?

Recursion Pharmaceuticals, Inc.'s AOCI increased by 88.5% year-over-year, from $14.15M to $26.66M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Recursion Pharmaceuticals, Inc. RXRX AOCI

AOCI at other companies

SchrodingerSDGR

-$28K-131%

Absci CorporationABSI

$304K+1,500%

AbCellera Biologics Inc.ABCL

-$2.42M+65.4%

Relay Therapeutics, Inc.RLAY

-$172K-553%

Septerna, Inc.SEPN

-$569K-387%

Ligand PharmaceuticalsLGND

$5.39M+445%

Other financials

Income statement

See full

Revenue$6.5M-56.1%

Gross profit-$6.0M+15.0%

Operating income-$128.5M+32.8%

Net income-$117.5M+42.0%

EPS (diluted)-$0.22+56.0%

Balance sheet

See full

Cash & equivalents$665.2M+30.6%

Total debt$88.6M-24.6%

Total equity$1.0B+9.7%

Total assets$1.3B+2.6%

Cash flow

See full

Operating cash flow-$81.1M+38.5%

CapEx$258.0K-85.9%

Free cash flow-$81.4M+39.2%

Valuation

See full

Market cap$1.71B-23.7%

Enterprise value$1.14B-39.8%

P/S25.8×-11.8×

Profitability

See full

Gross margin7.2%—

Operating margin-881.3%-66.8pp

Net margin-842.9%-92.4pp

FCF margin-490.7%-102pp

Returns & leverage

See full

Return on equity-57.2%-14.4pp

Debt / equity0.1×0.0×

Current ratio5.5×+1.4×

Where this comes from

Reported directly by Recursion Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Recursion Pharmaceuticals, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Recursion Pharmaceuticals, Inc.'s AOCI?: Recursion Pharmaceuticals, Inc. (RXRX) reported AOCI of $26.66M in Q1 2026.
How has Recursion Pharmaceuticals, Inc.'s AOCI changed year-over-year?: Recursion Pharmaceuticals, Inc.'s AOCI increased by 88.5% year-over-year, from $14.15M to $26.66M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.